These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15864374)

  • 1. Relationship between thymidylate synthase (TS) genotype and TS expression: a tissue microarray analysis of colorectal cancers.
    Popat S; Wort R; Houlston RS
    Int J Surg Pathol; 2005 Apr; 13(2):127-33. PubMed ID: 15864374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.
    Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R
    Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
    Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L
    Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas.
    Kristensen MH; Weidinger M; Bzorek M; Pedersen PL; Mejer J
    J Int Med Res; 2010; 38(2):484-97. PubMed ID: 20515563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
    Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G
    Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
    Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
    Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of thymidylate synthase in primary colorectal adenocarcinoma.
    Lindebjerg J; Nielsen JN; Hoeffding LD; Bisgaard C; Brandslund I; Jakobsen A
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):37-41. PubMed ID: 16540728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
    Iacopetta B; Grieu F; Joseph D; Elsaleh H
    Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer.
    Chen J; Hunter DJ; Stampfer MJ; Kyte C; Chan W; Wetmur JG; Mosig R; Selhub J; Ma J
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):958-62. PubMed ID: 14578129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene.
    Uchida K; Hayashi K; Kawakami K; Schneider S; Yochim JM; Kuramochi H; Takasaki K; Danenberg KD; Danenberg PV
    Clin Cancer Res; 2004 Jan; 10(2):433-9. PubMed ID: 14760062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.
    Kawakami K; Omura K; Kanehira E; Watanabe Y
    Anticancer Res; 1999; 19(4B):3249-52. PubMed ID: 10652619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
    Etienne MC; Chazal M; Laurent-Puig P; Magné N; Rosty C; Formento JL; Francoual M; Formento P; Renée N; Chamorey E; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
    J Clin Oncol; 2002 Jun; 20(12):2832-43. PubMed ID: 12065560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
    J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
    Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer.
    Broll R; Busch P; Duchrow M; Oevermann E; Schwandner O; Farke S; Bruch HP; Windhövel U
    Int J Colorectal Dis; 2005 Mar; 20(2):94-102. PubMed ID: 15309465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer.
    Hur H; Kang J; Kim NK; Min BS; Lee KY; Shin SJ; Keum KC; Choi J; Kim H; Choi SH; Lee MY
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):669-76. PubMed ID: 20932673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity.
    Kawakami K; Ishida Y; Danenberg KD; Omura K; Watanabe G; Danenberg PV
    Jpn J Cancer Res; 2002 Nov; 93(11):1221-9. PubMed ID: 12460463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
    Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV
    Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil.
    Aschele C; Debernardis D; Tunesi G; Maley F; Sobrero A
    Clin Cancer Res; 2000 Dec; 6(12):4797-802. PubMed ID: 11156237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.